Global Product Supply

It is LEO Pharma's goal to establish the most efficient and professional Global Product Supply set-up to support product sales, and ensure the best quality and rapid delivery of LEO products to customers at a reasonable cost.

To deliver this, the Global Product Supply organisation is committed to continuous improvements within customer service, production costs, product quality and compliance. 

Pharmaceutical manufacturing plants are subject to international rules of Good Manufacturing Practice (GMP) and quality assurance. Plants involved in supply to the US are approved by the US Federal Drug Administration (FDA). 

More than 950 employees work in our six production plants situated in Denmark, France, Ireland, and Australia.

We use cookies on this website

The cookies help us gain a better understanding of how you use our website; display applications and functionalities, to optimise your website experience, to assign a unique identification number to you, and to help you remember your user ID and password when you return to the website. We also use cookies to generate statistical information.

By continuing to browse our website, you are agreeing to our use of cookies

If you want to know more about our cookie policy and how to avoid and delete cookies click here.